Citation: Hj. Van Der Woude et R. Aalbers, Compliance with inhaled glucocorticoids and concomitant use of long-actingbeta(2)-agonists, RESP MED, 95(5), 2001, pp. 404-407
Citation: Hj. Van Der Woude et R. Aalbers, Unaltered perception of dyspnoea during treatment with long-acting beta(2)-agonists, EUR RESP J, 18(2), 2001, pp. 269-271
Citation: Hj. Van Der Woude et al., Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta(2) agonists, THORAX, 56(7), 2001, pp. 529-535
Authors:
van Roggen, JF
Bovee, JVMG
van der Woude, HJ
Hogendoorn, PCW
Citation: Jf. Van Roggen et al., An update of diagnostic strategies using molecular genetic and magnetic resonance imaging techniques for musculoskeletal tumors, CURR OP RH, 12(1), 2000, pp. 77-83
Authors:
Egmont-Petersen, M
Hogendoorn, PCW
van der Geest, RJ
Vrooman, HA
van der Woude, HJ
Janssen, JP
Bloem, JL
Reiber, JHC
Citation: M. Egmont-petersen et al., Detection of areas with viable remnant tumor in postchemotherapy patients with Ewing's sarcoma by dynamic contrast-enhanced MRI using pharmacokineticmodeling, MAGN RES IM, 18(5), 2000, pp. 525-535
Authors:
Bovee, JVMG
van Roggen, JFG
Cleton-Jansen, AM
Taminiau, AHM
van der Woude, HJ
Hogendoorn, PCW
Citation: Jvmg. Bovee et al., Malignant progression in multiple enchondromatosis (Ollier's disease): An autopsy-based molecular genetic study, HUMAN PATH, 31(10), 2000, pp. 1299-1303